VC
Vaccinex, Inc.
VCNX · OTC
$1.00 +0.00% (+$0.00)
1M -4.76%
Market Cap $2.68M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
40 /100
Fair P/S 4.45x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Rev. growth 12.59%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 95.51%
FCF margin 2,696.84%
Net margin 3,100.50%
Quality
61 /100
Average ROIC 760.66%
Asset turnover 0.23x
ROA 717.80%
Debt
3 /100
High Current ratio 0.50x
Int. coverage -620.13x
Debt/Equity N/A
Stability
52 /100
Moderate Beta 0.68x
Profitable years 0
Rev. volatility 299.19%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VCNX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Maurice Zauderer
Employees
25
Headquarters
Rochester
Prihajajoči dogodki
16 NOV.
Earnings
Upcoming earnings report